Using cortactin mutants, Li et al. reported that cortactin phosphorylation promoted metastasis in breast cancer cells; cortactin that was deficient in tyrosine phosphorylation induced more than 70% fewer bone metastases than wild type cortactin-expressing cells [36]. The gene discussed is CTTN; the disease is breast carcinoma.